WhitTier Trust Company’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4K Sell
216
-228
-51% -$27.6K ﹤0.01% 886
2026
Q1
$72.7K Buy
444
+206
+87% +$31.7K ﹤0.01% 651
2025
Q4
$41.7K Sell
238
-2
-0.8% -$365 ﹤0.01% 743
2025
Q3
$37.7K Buy
240
+151
+170% +$18.5K ﹤0.01% 756
2025
Q2
$8.96K Buy
89
+87
+4,350% +$6.65K ﹤0.01% 1151
2025
Q1
$152 Hold
2
﹤0.01% 1399
2024
Q4
$138 Buy
+2
New +$144 ﹤0.01% 1328

Other funds holding INSM

WhitTier Trust Company's INSM Position: Q2 2026 in Review

WhitTier Trust Company reduced its Insmed (INSM) stake by 51% in Q2 2026, selling an estimated $27.6K and leaving 216 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

WhitTier Trust Company first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $72.7K in Q1 2026. 281 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • WhitTier Trust Company held 216 shares of Insmed worth $24.4K as of Q2 2026.
  • WhitTier Trust Company sold 228 Insmed shares in Q2 2026, an estimated $27.6K.
  • Insmed made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #886 holding.
  • WhitTier Trust Company first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • WhitTier Trust Company's Insmed position peaked at $72.7K in Q1 2026.
  • 281 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.